Prime Medicine Logo

Prime Medicine

🇺🇸
PRME
US74168J1016

Prime Medicine is a leading biotechnology company focused on precise gene editing. Utilizing its innovative Prime Editing technology, it is developing transformative therapies to address a wide spectrum of genetic diseases. The company aims to fundamentally correct genomic defects, revolutionizing medicine.

Next Quarterly Earnings

Thursday, August 6, 2026
CW 32
Pre-Market
In 32 days

Stock Price

All Dates

Company Information

Name
Prime Medicine
Ticker Symbol
PRME
ISIN
US74168J1016
Country
🇺🇸
USA
More Financial Information